Since its approval in 1984 by the United States Food and Drug Administration for over- thecounter (OTC) use as the first nonaspirin nonsteroidal anti-inflammatory drug (NSAID) …
EF Barreto, MA Feely - Kidney360, 2020 - journals.lww.com
Nearly 60% of patients with CKD suffer pain. Of those patients with CKD who have pain, most rate their pain as moderate or severe in intensity. Undermanaged pain is associated …
LA Wagner, JC Fink - Seminars in Nephrology, 2017 - Elsevier
Patients with chronic kidney disease (CKD) are at risk for complications both inherent to the disease and as a consequence of its treatment. The dangers that CKD patients face change …
SZ Alshammari - Journal of Pharmaceutical Research …, 2023 - public.paper4promo.com
Introduction: Diclofenac was identified by the Pharmacovigilance Risk Assessment Committee of the European Medicines Agency as a high-risk NSAID in terms of its effects on …
Introduction: Analgesic nephropathy is a preventable cause of chronic renal failure that occurs due to excessive use of over the counter (OTC) analgesics. Misuse or long term use …
Introduction: Portugal presents the highest incidence of stage 5 chronic kidney disease in Europe. It is speculated that a high consumption of non-steroidal anti-inflammatory drugs …
AA Al Mousa, IA Qureshi, F Anwar, NS Butt… - …, 2021 - proceedings-szmc.org.pk
Introduction: Chronic kidney disease (CKD) has become a global health problem. Growing prevalence rates of diabetes mellitus (DM) and hypertension further add on to potential …